(NYSE: TFX) Teleflex's forecast annual revenue growth rate of 5.64% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 6.46%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.77%.
Teleflex's revenue in 2023 is $2,791,041,000.On average, 12 Wall Street analysts forecast TFX's revenue for 2023 to be $139,007,792,639, with the lowest TFX revenue forecast at $135,391,637,436, and the highest TFX revenue forecast at $142,728,539,420. On average, 10 Wall Street analysts forecast TFX's revenue for 2024 to be $146,946,096,194, with the lowest TFX revenue forecast at $139,227,444,341, and the highest TFX revenue forecast at $152,033,809,825.
In 2025, TFX is forecast to generate $154,266,286,060 in revenue, with the lowest revenue forecast at $146,489,705,119 and the highest revenue forecast at $158,483,467,280.